Skip to main content
Erschienen in: Journal of General Internal Medicine 4/2009

01.04.2009 | Original Article

Providers’ Experiences Treating Chronic Pain Among Opioid-Dependent Drug Users

verfasst von: Karina M. Berg, MD, MS, Julia H. Arnsten, MD, MPH, Galit Sacajiu, MD, MPH, Alison Karasz, PhD

Erschienen in: Journal of General Internal Medicine | Ausgabe 4/2009

Einloggen, um Zugang zu erhalten

Abstract

BACKGROUND

Successful management of chronic pain with opioid medications requires balancing opioid dependence and addiction with pain relief and restoration of function. Evaluating these risks and benefits is difficult among patients with chronic pain and pre-existing addiction, and the ambiguity is increased for patients on methadone maintenance therapy for opioid dependence. Providers treating both chronic pain and addiction routinely make diagnostic and therapeutic decisions, but decision-making strategies in this context have not been well described.

OBJECTIVE

Our objective was twofold. We sought first to explore providers’ perceptions of ambiguity, and then to examine their strategies for making diagnostic and treatment decisions to manage chronic pain among patients on methadone maintenance therapy.

DESIGN

Qualitative semi-structured interviews.

SETTING AND PARTICIPANTS

We interviewed health-care providers delivering integrated medical care and substance abuse treatment to patients in a methadone maintenance program.

RESULTS

Providers treating pain and co-morbid addiction described ambiguity in all diagnostic and therapeutic decisions. To cope with this inherent ambiguity, most providers adopted one of two decision-making frameworks, which determined clinical behavior. One framework prioritized addiction treatment by emphasizing the destructive consequences of abusing illicit drugs or prescription medications; the other prioritized pain management by focusing on the destructive consequences of untreated pain. Identification with a decision-making framework shaped providers’ experiences, including their treatment goals, perceptions of treatment risks, pain management strategies, and tolerance of ambiguity. Adherence to one of these two frameworks led to wide variation in pain management practices, which created tension among providers.

CONCLUSIONS

Providers delivering integrated medical care and substance abuse treatment to patients in a methadone maintenance program found tremendous ambiguity in the management of chronic pain. Most providers adopted one of the two divergent heuristic frameworks we identified, which resulted in significant variations in pain management. To reduce variation and determine best practices, studies should examine clinically relevant endpoints, including pain, illicit drug use, prescription drug abuse, and functional status. Until then, providers managing chronic pain in patients with co-morbid addiction should attempt to reduce tension by acknowledging ambiguity and engaging in open discourse.
Literatur
1.
Zurück zum Zitat Gerrity MS, Devellis RF, Earp JA. Physicians’ reactions to uncertainty in patient care. A new measure and new insights. Med Care. 1990;28(8):724-36.PubMedCrossRef Gerrity MS, Devellis RF, Earp JA. Physicians’ reactions to uncertainty in patient care. A new measure and new insights. Med Care. 1990;28(8):724-36.PubMedCrossRef
2.
3.
Zurück zum Zitat Naylor CD. Grey zones of clinical practice: some limits to evidence-based medicine. Lancet. 1995;345(8953):840-2.PubMedCrossRef Naylor CD. Grey zones of clinical practice: some limits to evidence-based medicine. Lancet. 1995;345(8953):840-2.PubMedCrossRef
4.
Zurück zum Zitat Zerzan JT, Morden NE, Soumerai S, et al. Trends and geographic variation of opiate medication use in state Medicaid fee-for-service programs, 1996 to 2002. Med Care. 2006;44(11):1005-10.PubMedCrossRef Zerzan JT, Morden NE, Soumerai S, et al. Trends and geographic variation of opiate medication use in state Medicaid fee-for-service programs, 1996 to 2002. Med Care. 2006;44(11):1005-10.PubMedCrossRef
5.
Zurück zum Zitat Eriksen J, Sjogren P, Bruera E, Ekholm O, Rasmussen NK. Critical issues on opioids in chronic non-cancer pain: an epidemiological study. Pain. 2006;125(1-2):172-9.PubMedCrossRef Eriksen J, Sjogren P, Bruera E, Ekholm O, Rasmussen NK. Critical issues on opioids in chronic non-cancer pain: an epidemiological study. Pain. 2006;125(1-2):172-9.PubMedCrossRef
6.
Zurück zum Zitat Turk DC, Brody MC, Okifuji EA. Physicians’ attitudes and practices regarding the long-term prescribing of opioids for non-cancer pain. Pain. 1994;59(2):201-8.PubMedCrossRef Turk DC, Brody MC, Okifuji EA. Physicians’ attitudes and practices regarding the long-term prescribing of opioids for non-cancer pain. Pain. 1994;59(2):201-8.PubMedCrossRef
7.
Zurück zum Zitat Tamayo-Sarver JH, Dawson NV, Cydulka RK, Wigton RS, Baker DW. Variability in emergency physician decision making about prescribing opioid analgesics. Ann Emerg Med. 2004;43(4):483-93.PubMedCrossRef Tamayo-Sarver JH, Dawson NV, Cydulka RK, Wigton RS, Baker DW. Variability in emergency physician decision making about prescribing opioid analgesics. Ann Emerg Med. 2004;43(4):483-93.PubMedCrossRef
8.
Zurück zum Zitat Potter M, Schafer S, Gonzalez-Mendez E, et al. Opioids for chronic nonmalignant pain. Attitudes and practices of primary care physicians in the UCSF/Stanford Collaborative Research Network. University of California, San Francisco. J Fam Pract. 2001;50(2):145-51.PubMed Potter M, Schafer S, Gonzalez-Mendez E, et al. Opioids for chronic nonmalignant pain. Attitudes and practices of primary care physicians in the UCSF/Stanford Collaborative Research Network. University of California, San Francisco. J Fam Pract. 2001;50(2):145-51.PubMed
9.
Zurück zum Zitat Bendtsen P, Hensing G, Ebeling C, Schedin A. What are the qualities of dilemmas experienced when prescribing opioids in general practice? Pain. 1999;82(1):89-96.PubMedCrossRef Bendtsen P, Hensing G, Ebeling C, Schedin A. What are the qualities of dilemmas experienced when prescribing opioids in general practice? Pain. 1999;82(1):89-96.PubMedCrossRef
10.
Zurück zum Zitat Passik SD, Kirsh KL, Whitcomb L, Dickerson PK, Theobald DE. Pain clinicians’ rankings of aberrant drug-taking behaviors. J Pain Palliat Care Pharmacother. 2002;16(4):39-49.PubMedCrossRef Passik SD, Kirsh KL, Whitcomb L, Dickerson PK, Theobald DE. Pain clinicians’ rankings of aberrant drug-taking behaviors. J Pain Palliat Care Pharmacother. 2002;16(4):39-49.PubMedCrossRef
11.
Zurück zum Zitat Collins ED, Streltzer J. Should opioid analgesics be used in the management of chronic pain in opiate addicts? Am J Addict. 2003;12(2):93-100.PubMedCrossRef Collins ED, Streltzer J. Should opioid analgesics be used in the management of chronic pain in opiate addicts? Am J Addict. 2003;12(2):93-100.PubMedCrossRef
12.
Zurück zum Zitat Hicks RD. Pain management in the chemically dependent patient. Hawaii Med J. 1989;48(11):491-5.PubMed Hicks RD. Pain management in the chemically dependent patient. Hawaii Med J. 1989;48(11):491-5.PubMed
13.
Zurück zum Zitat Merrill JO, Rhodes LA, Deyo RA, Marlatt GA, Bradley KA. Mutual mistrust in the medical care of drug users: the keys to the "narc" cabinet. J Gen Intern Med. 2002;17(5):327-33.PubMed Merrill JO, Rhodes LA, Deyo RA, Marlatt GA, Bradley KA. Mutual mistrust in the medical care of drug users: the keys to the "narc" cabinet. J Gen Intern Med. 2002;17(5):327-33.PubMed
14.
Zurück zum Zitat Trafton JA, Oliva EM, Horst DA, Minkel JD, Humphreys K. Treatment needs associated with pain in substance use disorder patients: implications for concurrent treatment. Drug Alcohol Depend. 2004;73(1):23-31.PubMedCrossRef Trafton JA, Oliva EM, Horst DA, Minkel JD, Humphreys K. Treatment needs associated with pain in substance use disorder patients: implications for concurrent treatment. Drug Alcohol Depend. 2004;73(1):23-31.PubMedCrossRef
15.
Zurück zum Zitat Gilson AM, Joranson DE. U.S. policies relevant to the prescribing of opioid analgesics for the treatment of pain in patients with addictive disease. Clin J Pain. 2002;18(4 Suppl):S91-8.PubMedCrossRef Gilson AM, Joranson DE. U.S. policies relevant to the prescribing of opioid analgesics for the treatment of pain in patients with addictive disease. Clin J Pain. 2002;18(4 Suppl):S91-8.PubMedCrossRef
16.
Zurück zum Zitat Cohen MJ, Jasser S, Herron PD, Margolis CG. Ethical perspectives: opioid treatment of chronic pain in the context of addiction. Clin J Pain. 2002;18(4 Suppl):S99-107.PubMedCrossRef Cohen MJ, Jasser S, Herron PD, Margolis CG. Ethical perspectives: opioid treatment of chronic pain in the context of addiction. Clin J Pain. 2002;18(4 Suppl):S99-107.PubMedCrossRef
17.
Zurück zum Zitat Michna E, Ross EL, Hynes WL, et al. Predicting aberrant drug behavior in patients treated for chronic pain: importance of abuse history. J Pain Symptom Manage. 2004;28(3):250-8.PubMedCrossRef Michna E, Ross EL, Hynes WL, et al. Predicting aberrant drug behavior in patients treated for chronic pain: importance of abuse history. J Pain Symptom Manage. 2004;28(3):250-8.PubMedCrossRef
18.
Zurück zum Zitat Ives TJ, Chelminski PR, Hammett-Stabler CA, et al. Predictors of opioid misuse in patients with chronic pain: a prospective cohort study. BMC Health Serv Res. 2006;6:46.PubMedCrossRef Ives TJ, Chelminski PR, Hammett-Stabler CA, et al. Predictors of opioid misuse in patients with chronic pain: a prospective cohort study. BMC Health Serv Res. 2006;6:46.PubMedCrossRef
19.
Zurück zum Zitat Alford DP, Compton P, Samet JH. Acute pain management for patients receiving maintenance methadone or buprenorphine therapy. Ann Intern Med. 2006;144(2):127-34.PubMed Alford DP, Compton P, Samet JH. Acute pain management for patients receiving maintenance methadone or buprenorphine therapy. Ann Intern Med. 2006;144(2):127-34.PubMed
20.
Zurück zum Zitat Rosenblum A, Joseph H, Fong C, Kipnis S, Cleland C, Portenoy RK. Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities. JAMA. 2003;289(18):2370-78.PubMedCrossRef Rosenblum A, Joseph H, Fong C, Kipnis S, Cleland C, Portenoy RK. Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities. JAMA. 2003;289(18):2370-78.PubMedCrossRef
21.
Zurück zum Zitat Jamison RN, Kauffman J, Katz NP. Characteristics of methadone maintenance patients with chronic pain. J Pain Symptom Manage. 2000;19(1):53-62.PubMedCrossRef Jamison RN, Kauffman J, Katz NP. Characteristics of methadone maintenance patients with chronic pain. J Pain Symptom Manage. 2000;19(1):53-62.PubMedCrossRef
22.
Zurück zum Zitat Crabtree BF, Miller WL. Doing Qualitative Research. California: SAGE Publications; 1999. Crabtree BF, Miller WL. Doing Qualitative Research. California: SAGE Publications; 1999.
23.
Zurück zum Zitat Landon BE, Reschovsky J, Reed M, Blumenthal D. Personal, organizational, and market level influences on physicians’ practice patterns: results of a national survey of primary care physicians. Med Care. 2001;39(8):889-905.PubMedCrossRef Landon BE, Reschovsky J, Reed M, Blumenthal D. Personal, organizational, and market level influences on physicians’ practice patterns: results of a national survey of primary care physicians. Med Care. 2001;39(8):889-905.PubMedCrossRef
24.
Zurück zum Zitat Vickrey BG, Gifford DR, Belin TR, et al. Practice styles of US compared to UK neurologists. Neurology. 1998;50(6):1661-8.PubMed Vickrey BG, Gifford DR, Belin TR, et al. Practice styles of US compared to UK neurologists. Neurology. 1998;50(6):1661-8.PubMed
25.
Zurück zum Zitat Fuat A, Hungin AP, Murphy JJ. Barriers to accurate diagnosis and effective management of heart failure in primary care: qualitative study. BMJ. 2003;326(7382):196.PubMedCrossRef Fuat A, Hungin AP, Murphy JJ. Barriers to accurate diagnosis and effective management of heart failure in primary care: qualitative study. BMJ. 2003;326(7382):196.PubMedCrossRef
26.
Zurück zum Zitat Coulter A, Klassen A, MacKenzie IZ, McPherson K. Diagnostic dilatation and curettage: is it used appropriately? BMJ. 1993;306(6872):236-9.PubMedCrossRef Coulter A, Klassen A, MacKenzie IZ, McPherson K. Diagnostic dilatation and curettage: is it used appropriately? BMJ. 1993;306(6872):236-9.PubMedCrossRef
27.
Zurück zum Zitat D’Aunno T, Vaughn TE. Variations in methadone treatment practices. Results from a national study. JAMA. 1992;267(2):253-8.PubMedCrossRef D’Aunno T, Vaughn TE. Variations in methadone treatment practices. Results from a national study. JAMA. 1992;267(2):253-8.PubMedCrossRef
28.
Zurück zum Zitat Willenbring ML, Hagedorn HJ, Postier AC, Kenny M. Variations in evidence-based clinical practices in nine United States Veterans Administration opioid agonist therapy clinics. Drug Alcohol Depend. 2004;75(1):97-106.PubMedCrossRef Willenbring ML, Hagedorn HJ, Postier AC, Kenny M. Variations in evidence-based clinical practices in nine United States Veterans Administration opioid agonist therapy clinics. Drug Alcohol Depend. 2004;75(1):97-106.PubMedCrossRef
29.
Zurück zum Zitat Cranney M, Walley T. Same information, different decisions: the influence of evidence on the management of hypertension in the elderly. Br J Gen Pract. 1996;46(412):661-3.PubMed Cranney M, Walley T. Same information, different decisions: the influence of evidence on the management of hypertension in the elderly. Br J Gen Pract. 1996;46(412):661-3.PubMed
30.
Zurück zum Zitat Ghosh AK, Ghosh K. Translating evidence-based information into effective risk communication: current challenges and opportunities. J Lab Clin Med. 2005;145(4):171-80.PubMedCrossRef Ghosh AK, Ghosh K. Translating evidence-based information into effective risk communication: current challenges and opportunities. J Lab Clin Med. 2005;145(4):171-80.PubMedCrossRef
31.
Zurück zum Zitat Freeman AC, Sweeney K. Why general practitioners do not implement evidence: qualitative study. BMJ. 2001;323(7321):1100-02.PubMedCrossRef Freeman AC, Sweeney K. Why general practitioners do not implement evidence: qualitative study. BMJ. 2001;323(7321):1100-02.PubMedCrossRef
32.
Zurück zum Zitat Karasz A, Zallman L, Berg K, Gourevitch M, Selwyn P, Arnsten JH. The experience of chronic severe pain in patients undergoing methadone maintenance treatment. J Pain Symptom Manage. 2004;28(5):517-25.PubMedCrossRef Karasz A, Zallman L, Berg K, Gourevitch M, Selwyn P, Arnsten JH. The experience of chronic severe pain in patients undergoing methadone maintenance treatment. J Pain Symptom Manage. 2004;28(5):517-25.PubMedCrossRef
33.
Zurück zum Zitat Kuhn TS. The Structure of Scientific Revolutions. 3Chicago and London: The University of Chicago Press; 2008. Kuhn TS. The Structure of Scientific Revolutions. 3Chicago and London: The University of Chicago Press; 2008.
35.
Zurück zum Zitat Tomlin Z, Humphrey C, Rogers S. General practitioners’ perceptions of effective health care. BMJ. 1999;318(7197):1532-5.PubMed Tomlin Z, Humphrey C, Rogers S. General practitioners’ perceptions of effective health care. BMJ. 1999;318(7197):1532-5.PubMed
Metadaten
Titel
Providers’ Experiences Treating Chronic Pain Among Opioid-Dependent Drug Users
verfasst von
Karina M. Berg, MD, MS
Julia H. Arnsten, MD, MPH
Galit Sacajiu, MD, MPH
Alison Karasz, PhD
Publikationsdatum
01.04.2009
Verlag
Springer-Verlag
Erschienen in
Journal of General Internal Medicine / Ausgabe 4/2009
Print ISSN: 0884-8734
Elektronische ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-009-0908-x

Weitere Artikel der Ausgabe 4/2009

Journal of General Internal Medicine 4/2009 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

CAR-M-Zellen: Warten auf das große Fressen

22.05.2024 Onkologische Immuntherapie Nachrichten

Auch myeloide Immunzellen lassen sich mit chimären Antigenrezeptoren gegen Tumoren ausstatten. Solche CAR-Fresszell-Therapien werden jetzt für solide Tumoren entwickelt. Künftig soll dieser Prozess nicht mehr ex vivo, sondern per mRNA im Körper der Betroffenen erfolgen.

Frühzeitige HbA1c-Kontrolle macht sich lebenslang bemerkbar

22.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes von Anfang an intensiv BZ-senkend zu behandeln, wirkt sich positiv auf Komplikationen und Mortalität aus – und das offenbar lebenslang, wie eine weitere Nachfolgeuntersuchung der UKPD-Studie nahelegt.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.